• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of September 25, 2013

  • Print
  • Share
  • E-mail

Product Detail

Product Description Platelets Pheresis Leukocytes Reduced, Apheresis
Recall Number B-2181-13
Classification Class II
Code Info 0747488A ;0747488B ; 07474888C; ; 0748326A; 0748326B; 0748804A ; 0748804B; 0748804C; 0749147B; 0749451A; 0749451B; 749451C; 0749736A; 0749736B; 0749736C; 0749987A; 0749987B; 0749987C; 0750284C; 0750578A; 0750578B; 0750578C; 0750898A; 0750898B; 0750898C; 0752017A; 0752017B; 0752301A, 0752301C; W313710000269A, ; W313710000269B; W313710000269C; W313710000963A; W313710000963B; W313710001251A; W313710001251B; W313710001251C; 0751390A, 0751390B
Product Distributed Qty 39 units
Reason For Recall Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.

Event Detail

Event Id 57059
Product Type Biologics
Status Terminated
Recalling Firm HemaCare Corporation
City Van Nuys
State CA
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2010-09-20
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern CA